Showing results (1081-1090 of 1,116) with videos related to
Sort By:
Pageof 112
Molecular Psychiatry|October 28, 2015
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorderJ Song, S E Bergen, A Di Florio, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 9, 2015
Independent evidence for an association between general cognitive ability and a genetic locus for educational attainmentJoey W Trampush, Todd Lencz, Emma Knowles, et al.Translational Psychiatry|January 11, 2017
Evidence for genetic heterogeneity between clinical subtypes of bipolar disorderA W Charney, D M Ruderfer, E A Stahl, et al.Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 15, 2022
Effects of individual differences, society, and culture on youth-rated problems and strengths in 38 societiesMasha Y Ivanova, Thomas M Achenbach, Lori Turner, et al.Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 25, 2018
Testing Syndromes of Psychopathology in Parent and Youth Ratings Across SocietiesMasha Y Ivanova, Thomas M Achenbach, Leslie A Rescorla, et al.Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Combinatorial effects of gene dosage, polygenic background and environment on complex traitsMolly F Sacks, Marieke Klein, Tim B Bigdeli, et al.Nature Medicine|September 14, 2024
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialKatia Khoury, Jane L Meisel, Christina Yau, et al.Nature Neuroscience|September 27, 2016
Gene expression elucidates functional impact of polygenic risk for schizophreniaMenachem Fromer, Panos Roussos, Solveig K Sieberts, et al.Nature Medicine|September 14, 2024
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialRebecca A Shatsky, Meghna S Trivedi, Christina Yau, et al.Nature Genetics|March 14, 2023
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populationsDongjing Liu, Dara Meyer, Brian Fennessy, et al.Pageof 112